Skip to main content
Clinical Trials/NCT06627426
NCT06627426
Recruiting
Not Applicable

Virtual Reality for Patient Informed Consent in Neurosurgery - a Randomized Controlled Trial

University Hospital, Basel, Switzerland1 site in 1 country34 target enrollmentOctober 22, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
VR-based Informed Consent
Sponsor
University Hospital, Basel, Switzerland
Enrollment
34
Locations
1
Primary Endpoint
Comparison of intensity of anxiety between intervention and control group
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this randomized controlled trial is to evaluate benefits of VR (virtual reality)-based patient informed consent in neurosurgery regarding subjective patient comprehension, patient-doctor relationship and anxiety.

Detailed Description

Additionally, the investigators aim to assess the cost-benefit radio as well as feasibility in a clinical routine setting. Considering the increasing patient participation in decision-making, VR could lead to better understanding of complex surgical procedures, improving the perioperative process for both, patient and surgeon, and reduce anxiety.

Registry
clinicaltrials.gov
Start Date
October 22, 2024
End Date
October 15, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients between the age of 18 and 75
  • Surgical clipping for intracranial aneurysm, resection of vascular malformations
  • Craniotomy and Resection of intracranial tumors that can be segmented for VR

Exclusion Criteria

  • Visual or auditory impairment with no sufficient aid
  • Patient that had VR informed consent for surgery before
  • Psychiatric illness, cognitive impairment

Outcomes

Primary Outcomes

Comparison of intensity of anxiety between intervention and control group

Time Frame: one time assessment at day 1

Comparison of intensity of physical and cognitive anxiety symptoms will be assessed by the questionnaire Beck Anxiety Inventory (BAI). This questionnaire consists of 21 self-reported items (four-point scale). min score: 39 (minimal anxiety level) max score:174 (severe anxiety)

Comparison of patient doctor relationship between intervention and control group

Time Frame: one time assessment at day 1

Comparison of patient doctor relationship will be assessed by PDRQ9 (patient-doctor relationship questionnaire). The questionnaire is a 9-item scale that assesses patients' perception of the relationship with the physician. Items are scored on a 5-point Likert scale ranging from 'not at all appropriate' to 'totally appropriate'. Raw sum scores range from 9 to 45, with higher scores indicating that the patient's perception of the patient-doctor relationship is more favorable.

Study Sites (1)

Loading locations...

Similar Trials